Home | Links | Contact Us | More About Intellectual Property | Bookmark
Search patents:
Home Molecular Biology Removal-of-heparin-from-blood-plasma-samples-using-an-insoluble-protamine-reaction-product

 Use of cyclic carbonic acid esters as solvents for poly-(.beta.-hydroxybutyric acid)
What is claimed is: 1. A process which comprises: extracting poly-(.beta.-hydroxybutyric acid) from ...


 Process for producing interferon
OF THE INVENTION The method of cultivating anchorage dependent cells such as diploid cells by ...


 Measurement of intracellular calcium using bioluminescent apoaequorin expressed in mammalian cells
OF THE INVENTION The present invention provide mammalian cells which express apoaequorin and a ...


 Process for production of an antibiotic compound using Zalerion arboricola
What is claimed is: 1. A method for producing a compound having the formula: ##STR4## as the ...


 Production of microorganisms having ice nucleating activity
OF THE INVENTION In conventional fermentation processes, the pH of the fermentation medium is ...


 Rapid and efficient regeneration of transgenic plants
OF THE INVENTION The present invention can be used with any plant species. It is particularly ...


 Treatment of waste rolling oil
What is claimed is: 1. A process for treating an oil and water emulsion wherein the oil and water ...


 Process for producing caprolactam from 6-aminocaproic acid
I claim: 1. In a process of converting 6-aminocaproic acid, dissolved in methanol or ethanol, to ...


 Chloramphenicol derivatives
What is claimed is: 1. A compound of the formula: ##STR4## wherein: R is an aliphatic linking group ...


 Chloramphenicol derivatives, antigens and antibodies
What is claimed is: 1. A compound of the formula: ##STR6## wherein: Q is chalcogen of atomic number ...


 Removal of heparin from blood plasma samples using an insoluble protamine reaction product

Details
Inventors: Babson, Arthur L.; Turner, James E.;
Assignee: Warner-Lambert Company (Morris Plains, NJ)
Primary Examiner: Schain; Howard E.
Assistant Examiner:
Attorney, Agent or Firm: Miller; Stephen I., Patton; Walter, Raines; Stephen

This invention relates to a method for the removal of heparin from heparin-containing plasma test samples using an insoluble protamine reaction product, without adversely affecting subsequent testing of the plasma for clotting time. Protamine sulfate or a combination of protamine sulfate and serum albumin is cross-linked with glutaraldehyde to form an insoluble reaction product which is capable of adsorbing heparin. According to the method of this invention, excess amounts of either of the cross-linked protamine reaction products are added to blood plasma samples containing heparin and the mixture is agitated for a time sufficient to permit adsorption of substantially all heparin present. The insoluble protamine heparin complex formed is removed from the plasma along with any excess insoluble protamine reaction product. Aliquots of the heparin-free plasma may be subjected to coagulation tests in order to determine true clotting time.

DETAILED DESCRIPTION We claim: 1.
A method for removing substantially all heparin from a heparin-containing blood plasma test sample which comprises: A.
Adding from about 10 to about 20 mg.
of the insoluble protamine/glutaraldehyde reaction product prepared by incubating an aqueous solution containing: I.
From about 1.
5 to about 2.
5 grams of protamine sulfate; II.
From about 20 to about 30 milliliters of water; III.
From about 20 to about 30 milliliters of phosphate buffer; and IV.
From about 6 to about 9 milliliters of a 10% solution of glutaraldehyde in phosphate buffer; at a pH of from about 6 to about 12 and a temperature of from about 4.
degree.
C.
to about 10.
degree.
C.
overnight; per milliliter of plasma to the plasma sample; B.
Agitating (A) until substantially all the heparin present in the plasma sample is adsorbed by and complexed with the insoluble protamine/glutaraldehyde reaction product; C.
Allowing (B) to stand for a time sufficient to allow precipitation of the free and complexed insoluble protamine/glutaraldehyde reaction product; D.
Removing the precipitate of (C) from the plasma sample to obtain substantially heparin-free plasma suitable for coagulation testing.
2.
A method according to claim 1 wherein, in Step A, about 14 mg.
of insoluble protamine/glutaraldehyde reaction product are added.
3.
A method according to claim 2 wherein, in Step B, the agitation is conducted for from about 10 to about 20 minutes.
4.
A method according to claim 3 wherein, in Step C, the plasma is allowed to stand for from about 2 to about 8 minutes.
5.
A method for removing substantially all heparin from a heparin-containing blood plasma test sample which comprises: A.
Adding from about 4 to about 14 mg.
of the insoluble protamine/serum albumin/glutaraldehyde reaction product, prepared by incubating an aqueous solution containing: I.
From about 0.
07 to about 0.
13 grams of serum albumin; II.
From about 0.
7 to about 1.
3 grams of protamine sulfate; III.
From about 20 to about 30 milliliters of water; and IV



Related patents
  Process of augmenting or enhancing the aroma of fabric softeners and detergents using cyclohexenyl-alpha-alkyl acrolein derivatives
OF THE DRAWINGS FIG. 2 is the GLC profile for the reaction product of Example I(B). The peak indicated by reference numeral "20" is the peak for the isocyclocitral ...
  Proteinaceous food product
We claim: 1. A method of making an edible proteinaceous food product comprising the steps of: fermenting carbohydrate in the presence of animal-derived proteinaceous ...
  Process for recovering L-amino acids from fermentation liquors containing them
Accordingly, it is an object of the present invention to develop a technique capable of removing both microbial cells and polymeric impurities from fermentation liquors ...
  Process for preparing an inhibiting agent against proliferation of animals malignant tumor cells
What we claim is: 1. A process for preparing an inhibiting agent against the proliferation of human renal carcinoma cells comprising cultivating human renal carcinoma ...
  Human lymphoblastold cell line and hybridomas derived therefrom
We claim: 1. A human lymphoblastoid B cell of the line LTR228 and progeny thereof. 2. A ouabain-resistant progeny of the lymphoblastoid B cell of claim 1. 3. A ...
  Taxol production by taxomyces andreanae
Accordingly, it is an object of the present invention to provide an improved process for producing taxol, using a taxol producing microbe followed by separation of taxol ...
  Intronic overexpression vectors
What is claimed is: 1. A non-naturally occurring DNA construct, said DNA construct comprising an external genetic element and an internal genetic element, said external ...
  CKS method of protein synthesis
This invention is a process for making proteins where a fusion protein of an E. coli enzyme, CKS (CTP:CMP-3-deoxy-D-manno-octulosonate cytidylyl transferase or CMP-KDO ...
  Direct bonding bracket positioning and mounting tool
What is claimed is: 1. An orthodontic tool particularly for positioning and holding a direct bonding bracket as it is positioned while permitting adhering cement applied ...
  High phosphate process for making low calcium, smooth flow xanthan gum
Aqueous compositions of xanthan gum tend to have a "chunky" or non-uniform flow characteristic. A "chunky" flow is an uneven, lumpy type of flow such as is encountered ...

0.054

Archive: All patents - Links

Copyright (c)2006 Eipa-patents.org - All rights reserved